𝔖 Bobbio Scriptorium
✦   LIBER   ✦

HER-2-Targeted Nanoparticle–Affibody Bioconjugates for Cancer Therapy

✍ Scribed by Frank Alexis; Pamela Basto; Etgar Levy-Nissenbaum; Aleksandar F. Radovic-Moreno; Liangfang Zhang; Eric Pridgen; Andrew Z. Wang; Shawn L. Marein; Katrina Westerhof; Linda K. Molnar; Omid C. Farokhzad

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
489 KB
Volume
3
Category
Article
ISSN
1860-7179

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeted nanoparticles for cancer therap
Targeted nanoparticles for cancer therapy
✍ Frank X. Gu; Rohit Karnik; Andrew Z. Wang; Frank Alexis; Etgar Levy-Nissenbaum; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 587 KB
Superparamagnetic Iron Oxide Nanoparticl
Superparamagnetic Iron Oxide Nanoparticle–Aptamer Bioconjugates for Combined Prostate Cancer Imaging and Therapy
✍ Andrew Z. Wang; Vaishali Bagalkot; Christophoros C. Vasilliou; Frank Gu; Frank A 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB

Over the past two decades, molecular targeted diagnostic and therapeutic agents have dramatically improved cancer diagnosis and treatment. [1][2][3][4][5][6][7][8] Targeting allows the preferential delivery of therapeutic, diagnostic, or imaging agents to the intended site. Advances in nanotechnolog

Affibody-displaying bionanocapsules for
Affibody-displaying bionanocapsules for specific drug delivery to HER2-expressing cancer cells
✍ Takuya Shishido; Hiroaki Mieda; Sang Youn Hwang; Yuya Nishimura; Tsutomu Tanaka; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 661 KB

A novel HER2-targeted carrier was developed using bionanocapsules (BNCs). Bionanocapsules (BNCs) are 100-nm hollow nanoparticles composed of the L-protein of hepatitis B virus surface antigen. An affibody of HER2 was genetically displayed on the BNC surface (Z(HER2)-BNC). For the investigation of bi

HER-2 status discrepancy between primary
HER-2 status discrepancy between primary breast cancer and metastatic sites. Impact on target therapy
✍ Alfredo Santinelli; Eleonora Pisa; Daniela Stramazzotti; Guidalberto Fabris 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 110 KB

## Abstract In this prospective study, we determined __HER‐2__ status in primary breast invasive carcinomas and in the paired lymph node metastases (synchronous and metachronous), local recurrence and metachronous distant metastases, to verify the percentage of discordant cases. HercepTest™ and Flu